Поисковый запрос: (<.>A=Neuvonen, P. J.$<.>) |
Общее количество найденных документов : 39
Показаны документы с 1 по 20
|
|
1.
| The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12h after the dose: Evidence for mechanism-based inhibition of CYP2C8 in vivo // Clin. Pharmacol. and Ther., 2008. Vol. 84, N 3.-С.403-411
|
2.
| Plasma concentrations of oral oxycodone are greatly increased in the elderly // Clin. Pharmacol. and Ther., 2008. Vol. 84, N 4.-С.462-464
|
3.
| Gemfibrozil markedly increases the plasma concentrations of montelukast: A previously unrecognized role for CYP2C8 in the metabolism of montelukast // Clin. Pharmacol. and Ther., 2010. Vol. 88, N 2.-С.223-230
|
4.
| The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12h after the dose: Evidence for mechanism-based inhibition of CYP2C8 in vivo // Clin. Pharmacol. and Ther., 2008. Vol. 84, N 3.-С.403-411
|
5.
| Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics // Clin. Pharmacol. and Ther., 2007. Vol. 81, N 5.-С.679-684
|
6.
| Lilja J.J. Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam-probes of CYP2C9, CYTP1A2, and CY3A4 // Clin. Pharmacol. and Ther., 2007. Vol. 81, N 6.-С.833-839
|
7.
| Lilja J.J. Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam-probes of CYP2C9, CYTP1A2, and CY3A4 // Clin. Pharmacol. and Ther., 2007. Vol. 81, N 6.-С.833-839
|
8.
| Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics // Clin. Pharmacol. and Ther., 2007. Vol. 81, N 5.-С.679-684
|
9.
| Different effects of SLCO1B1 polymorphisms on the pharmacokinetics of atorvastatin and rosuvastatin // Clin. Pharmacol. and Ther., 2007. Vol. 82, N 6.-С.726-733
|
10.
| UDP-glucuronosyltransferase (UGT) polymorphisms affect atorvastatin lactonization in vitro and in vivo // Clin. Pharmacol. and Ther., 2010. Vol. 87, N 1.-С.65-73, 19-20
|
11.
| Kivisto K.T. Sodium bicarbonate enhances the absorption and efficacy of glipizide // Clin. Pharmacol. and Ther., 1991. Vol. 49, N 2.-С.177
|
12.
| Kivisto K.T. Enhancement of absorption and efficacy of glipizide by magnesium hydroxide // Clin. Pharmacol. and Ther., 1991. Vol. 49, N 2.-С.127
|
13.
| The bioavailability of sustained release nicotinic acid formulations // Brit. J. Clin. Pharmacol., 1991. Vol. 32, N 4.-С.473-476
|
14.
| Prevention of chloroquine absorption by activated charcoal // Hum. and Exp. Toxicol., 1992. Vol. 11, N 2.-С.117-120
|
15.
| Kivisto K.T. Differential effects of sodium bicarbonate and aluminium hydroxide on the absorption and activity of glipizide // Eur. J. Clin. Pharmacol., 1991. Vol. 40, N 4.-С.383-386
|
16.
| Neuvonen P.J. Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids // Eur. J. Clin. Pharmacol., 1988. Vol. 35, N 5.-С.495-501
|
17.
| UDP-glucuronosyltransferase (UGT) polymorphisms affect atorvastatin lactonization in vitro and in vivo // Clin. Pharmacol. and Ther., 2010. Vol. 87, N 1.-С.65-73, 19-20
|
18.
| A controlled study with taltrimide and sodium valproate: valproate effective in partial epilepsy // Acta neurol. scand., 1990. Vol. 82, N 2.-С.121-125
|
19.
| The mechanism of the hypocholesterolaemic effect of activated charcoal // Eur. J. Clin. Invest, 1989. Vol. 19, N 3.-С.251-254
|
20.
| In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms - preferential inhibition of cytochrome P4502C9 (CYP2C9) // Brit. J. Clin. Pharmacol., 2001. Vol. 52, N 5.-С.547-553
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"